Eli Lilly is acquiring Ajax Therapeutics by paying up to $2.3B cash, composed of an upfront and milestone payments.
Lilly acquires Ajax Therapeutics for $2.3B cash
BK talks Biopharm
Biotech/Pharma Business Development and M&A
Eli Lilly is acquiring Ajax Therapeutics by paying up to $2.3B cash, composed of an upfront and milestone payments.
BK talks Biopharm 